questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Caractéristiques de la maladie
Maladie chronique
Hépatite chronique
Hépatite chronique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hépatite chronique : Questions médicales les plus fréquentes",
"headline": "Hépatite chronique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hépatite chronique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-22",
"dateModified": "2025-02-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hépatite chronique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladie chronique",
"url": "https://questionsmedicales.fr/mesh/D002908",
"about": {
"@type": "MedicalCondition",
"name": "Maladie chronique",
"code": {
"@type": "MedicalCode",
"code": "D002908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hépatite B chronique",
"alternateName": "Hepatitis B, Chronic",
"url": "https://questionsmedicales.fr/mesh/D019694",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite B chronique",
"code": {
"@type": "MedicalCode",
"code": "D019694",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500.477.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite C chronique",
"alternateName": "Hepatitis C, Chronic",
"url": "https://questionsmedicales.fr/mesh/D019698",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite C chronique",
"code": {
"@type": "MedicalCode",
"code": "D019698",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500.477.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite D chronique",
"alternateName": "Hepatitis D, Chronic",
"url": "https://questionsmedicales.fr/mesh/D019701",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite D chronique",
"code": {
"@type": "MedicalCode",
"code": "D019701",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.500.477.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hépatite chronique",
"alternateName": "Hepatitis, Chronic",
"code": {
"@type": "MedicalCode",
"code": "D006521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Heiner Wedemeyer",
"url": "https://questionsmedicales.fr/author/Heiner%20Wedemeyer",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hanover, Hanover, Germany."
}
},
{
"@type": "Person",
"name": "Grace Lai-Hung Wong",
"url": "https://questionsmedicales.fr/author/Grace%20Lai-Hung%20Wong",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China."
}
},
{
"@type": "Person",
"name": "Giuseppina Brancaccio",
"url": "https://questionsmedicales.fr/author/Giuseppina%20Brancaccio",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases, Department of Molecular Medicine, University of Padua, Padua, Italy."
}
},
{
"@type": "Person",
"name": "Giovanni B Gaeta",
"url": "https://questionsmedicales.fr/author/Giovanni%20B%20Gaeta",
"affiliation": {
"@type": "Organization",
"name": "Infectious Diseases, Department of Mental and Physical Health, Campania University, Naples, Italy. Electronic address: giovannibattista.gaeta@unicampania.it."
}
},
{
"@type": "Person",
"name": "Maria Buti",
"url": "https://questionsmedicales.fr/author/Maria%20Buti",
"affiliation": {
"@type": "Organization",
"name": "Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Research progress in protein microarrays: Focussing on cancer research.",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36316278",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/prca.202200036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Yield of Exome Sequencing in Fetuses with Sonographic Features of Skeletal Dysplasias but Normal Karyotype or Chromosomal Microarray Analysis: A Systematic Review.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37372383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes14061203"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessing the value of second-trimester nasal bone hypoplasia in predicting chromosomal abnormalities: a retrospective chromosomal microarray analysis of 351 fetuses.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36269386",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-022-06808-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estimation on risk of spontaneous abortions by genomic disorders from a meta-analysis of microarray results on large case series of pregnancy losses.",
"datePublished": "2023-04-04",
"url": "https://questionsmedicales.fr/article/37013615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mgg3.2181"
}
},
{
"@type": "ScholarlyArticle",
"name": "Epitranscriptomic profiling of m6A RNA methylation in renal epithelial tubular cells stimulated with calcium oxalate crystals through microarray analysis.",
"datePublished": "2023-03-22",
"url": "https://questionsmedicales.fr/article/36947229",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00240-023-01425-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Caractéristiques de la maladie",
"item": "https://questionsmedicales.fr/mesh/D020969"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladie chronique",
"item": "https://questionsmedicales.fr/mesh/D002908"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hépatite chronique",
"item": "https://questionsmedicales.fr/mesh/D006521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hépatite chronique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hépatite chronique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hépatite chronique",
"description": "Comment diagnostiquer l'hépatite chronique ?\nQuels tests sanguins sont utilisés ?\nQu'est-ce qu'une biopsie hépatique ?\nQuels sont les signes d'hépatite chronique ?\nL'échographie est-elle utile ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Microarray+Analysis&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hépatite chronique",
"description": "Quels sont les symptômes courants ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?\nLes démangeaisons sont-elles fréquentes ?\nY a-t-il des symptômes psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Microarray+Analysis&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hépatite chronique",
"description": "Comment prévenir l'hépatite chronique ?\nLa vaccination est-elle efficace ?\nQuels comportements à risque éviter ?\nL'hygiène joue-t-elle un rôle ?\nLes tests de dépistage sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Microarray+Analysis&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hépatite chronique",
"description": "Quels traitements existent pour l'hépatite chronique ?\nLes antiviraux sont-ils efficaces ?\nQuand faut-il envisager une transplantation ?\nY a-t-il des traitements naturels ?\nComment surveiller l'évolution de la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Microarray+Analysis&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hépatite chronique",
"description": "Quelles sont les complications possibles ?\nLa cirrhose est-elle réversible ?\nQuels signes indiquent une insuffisance hépatique ?\nLe cancer du foie est-il fréquent ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Microarray+Analysis&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hépatite chronique",
"description": "Quels sont les principaux facteurs de risque ?\nL'usage de drogues augmente-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes voyages à l'étranger sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D006521?mesh_terms=Microarray+Analysis&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hépatite chronique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des échographies et parfois une biopsie hépatique."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les marqueurs viraux, les enzymes hépatiques et les tests de fonction hépatique."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une biopsie hépatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un prélèvement de tissu hépatique pour évaluer l'inflammation et les lésions."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'hépatite chronique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent inclure fatigue, jaunisse, douleurs abdominales et démangeaisons."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie permet de visualiser des anomalies du foie et d'évaluer sa taille."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse se manifeste par une coloration jaune de la peau et des yeux."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes asymptomatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être asymptomatiques malgré une hépatite chronique."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons peuvent survenir en raison de l'accumulation de bile dans le sang."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression peuvent être des symptômes associés à l'hépatite chronique."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hépatite chronique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des comportements à risque sont essentiels."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre l'hépatite A et B est très efficace pour prévenir ces infections."
}
},
{
"@type": "Question",
"name": "Quels comportements à risque éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez le partage d'aiguilles, les rapports sexuels non protégés et l'usage de drogues."
}
},
{
"@type": "Question",
"name": "L'hygiène joue-t-elle un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle et alimentaire peut réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage régulier est crucial pour détecter l'hépatite chronique tôt."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'hépatite chronique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antiviraux, des immunomodulateurs et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les antiviraux sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antiviraux peuvent réduire la charge virale et améliorer la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une transplantation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements naturels peuvent aider, mais ils doivent être discutés avec un médecin."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'évolution de la maladie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers avec des tests sanguins et des échographies sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "La cirrhose est-elle réversible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la cirrhose est une condition irréversible, mais son évolution peut être ralentie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une insuffisance hépatique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, saignements, jaunisse et accumulation de liquide abdominal."
}
},
{
"@type": "Question",
"name": "Le cancer du foie est-il fréquent ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le cancer du foie peut survenir chez les patients atteints d'hépatite chronique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'infection virale, l'alcoolisme, et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'usage de drogues augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'usage de drogues injectables augmente le risque d'hépatite chronique."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux d'hépatite peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains groupes de sexe peuvent avoir un risque plus élevé d'infection virale."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à forte prévalence d'hépatite peut augmenter le risque d'infection."
}
}
]
}
]
}
Although several effective treatment modalities have been developed for cancers, the morbidity and mortality associated with cancer continues to increase every year. As one of the most exciting emergi...
Skeletal dysplasias are a group of diseases characterized by bone and joint abnormalities, which can be detected during prenatal ultrasound. Next-generation sequencing has rapidly revolutionized molec...
To evaluate the value of fetal nasal bone hypoplasia and other prenatal risk factors in predicting chromosomal abnormalities....
In this retrospective cohort study, we collected data on singleton pregnancies diagnosed with fetal nasal bone hypoplasia during second-trimester ultrasound. Fetal karyotyping and chromosomal microarr...
Our final analysis included 351 pregnancies, of which 62 (17.7%) fetuses had chromosomal abnormalities, including 36 cases of trisomy-21, six cases of trisomy-18, one case each of trisomy-13, and 47, ...
Nasal bone hypoplasia is a highly specific soft marker that is associated with multiple chromosomal abnormalities. The risk of chromosomal abnormalities increases when combined with structural abnorma...
A meta-analysis on seven large case series (>1000 cases) of chromosome microarray analysis (CMA) on products of conceptions (POC) evaluated the diagnostic yields of genomic disorders and syndromic pat...
The aim of this study was to investigate the relationship of m6A RNA methylation to CaOX-induced renal tubular injury. Microarray analysis was performed to detect the difference in mRNA expression and...
Recurrent implantation failure (RIF) refers to a challenging topic in assisted reproductive technology (ART), the etiology of which may be attributed to impaired endometrial receptivity; however, the ...
Four RIF microarray datasets were obtained from the Gene Expression Omnibus database and integrated by the "sva" R package. The differentially expressed genes (DEGs) were analyzed using the "limma" pa...
236 genes were differentially expressed in the endometrium of the RIF group. Functional enrichment analysis demonstrated that the biological functions of DEGs were mainly correlated to the immune-rela...
Abnormal immune response regulation of endometrium contributes to the occurrence of RIF, and γδ T cells may be the pivotal immune cells causing RIF. At the same time, the novel hub genes identified wi...
Circular RNAs, as covalently circularized RNA loops, have many unique biochemical properties. Many circRNA biological functions and clinical indications are being continually discovered. Increasingly,...
To identify potential proteins in the amniotic fluid (AF) that may be associated with histologic chorioamnionitis (HCA) in patients with preterm premature rupture of membranes (PPROM) using antibody-b...
This was a retrospective cohort study involving 100 singleton pregnant women with PPROM at 24-34 weeks who underwent amniocentesis and delivered within 120 h of amniocentesis. First, the AF proteomes ...
Of 507 proteins assessed in the microarray analysis, 46 showed significant intergroup differences. Further quantification confirmed that the levels of EN-RAGE, IL-6, MMP-9, TNFR2, SPARC, TSP2, and uPA...
Using protein-antibody microarray technology, we discovered several potential AF proteins (EN-RAGE, IL-6, MMP-9, and TNFR2) independently associated with HCA in patients with PPROM. Furthermore, we de...
This study aims to investigate the differences in the epigenomic patterns of N6-methyladenosine (m6A) methylation in gingival tissues between patients with periodontitis (PD) and healthy controls, ide...
As a multifactorial disease, PD involves multiple genetic and environmental effects. The m6A modification is the most prevalent internal mRNA modification and linked to various inflammatory diseases. ...
An m6A microarray of human gingival tissues was conducted in eight subjects: four diagnosed with PD and four healthy controls. Microarray analysis was performed to identify the differentially m6A meth...
In total, 458 DMGs, 750 DEGs, and 279 DMEGs were identified based on our microarray. Pathway analyses conducted for the DMEGs revealed that biological functions were mainly involved in the regulation ...
The current study exhibited a distinct m6A epitranscriptome, identified and verified two PD-related biomarkers (DNER and GNL2), which may provide novel insights into revealing the new molecular mechan...
Testicular germ cell tumours (TGCTs) are the most common solid malignancy among young men, and their incidence is still increasing. Despite good curability with cisplatin (CDDP)-based chemotherapy, ab...